| Chronic Lymphocytic Leukemia |
1 |
1 |
| Cancer |
0 |
0.92 |
| Biologic Therapy |
0 |
0.85 |
| Targeted Cancer Therapy |
0 |
0.77 |
| Skin Cancer |
0 |
0.73 |
| Antineoplastic Drug |
0 |
0.71 |
| Lung Cancer |
0 |
0.71 |
| Cancer Risk |
0 |
0.69 |
| Thyroid Disease |
0 |
0.53 |
| Acute Leukemia |
0 |
0.21 |
| Acute Myeloblastic Leukemia |
0 |
0.2 |
| Face |
0 |
0.17 |
| Leukemia |
0 |
0.17 |
| Sarcoma |
0 |
0.14 |
| Lung |
0 |
0.12 |
| Soft Tissue Sarcoma |
0 |
0.08 |
| Blood |
0 |
0.06 |
| Bronchus |
0 |
0.06 |
| Carcinogen |
0 |
0.06 |
| Health Education and Counseling |
0 |
0.06 |
| Hospital |
0 |
0.06 |
| Kidney |
0 |
0.06 |
| Match |
0 |
0.06 |
| Melanoma |
0 |
0.06 |
| Monoclonal Antibody |
0 |
0.06 |
| Ohio |
0 |
0.06 |
| Rectum |
0 |
0.06 |
| Thyroid |
0 |
0.06 |
| Tissue |
0 |
0.06 |
| Ultraviolet Light |
0 |
0.06 |